What is the recommended dosage of Chlorpheniramine (Chlorpheniramine) for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Chlorpheniramine for Children

The recommended dosage of chlorpheniramine for children is age-dependent: children 6 to under 12 years should receive 1/2 tablet (break tablet in half) every 4 to 6 hours, not exceeding 3 whole tablets in 24 hours, while children under 6 years of age should not use this product. 1

Dosage Guidelines by Age Group

Children under 6 years

  • Chlorpheniramine is not recommended for use in children under 6 years of age 1
  • The FDA drug label specifically contraindicates its use in this age group due to safety concerns 1

Children 6 to under 12 years

  • Dosage: 1/2 tablet every 4 to 6 hours 1
  • Maximum daily dose: 3 whole tablets in 24 hours 1
  • For parenteral administration in emergency settings (such as anaphylaxis): 2.5 mg IM or IV slowly 2

Children 12 years and older

  • Dosage: 1 tablet every 4 to 6 hours 1
  • Maximum daily dose: 6 tablets in 24 hours 1
  • For parenteral administration in emergency settings: 10 mg IM or IV slowly 2

Pharmacokinetic Considerations

  • Chlorpheniramine has a mean serum half-life of approximately 13.1 hours in children aged 6-16 years 3
  • The volume of distribution is relatively large at about 7.0 L/kg, suggesting significant tissue binding 3
  • Therapeutic serum concentrations range from 2.3 to 12.1 ng/mL for symptom suppression 3
  • Despite similar maximum concentration (Cmax) across age groups, the area under the curve (AUC) is approximately 15-30% higher in older children 4

Clinical Applications

Allergic Reactions

  • Chlorpheniramine is effective for managing allergic rhinitis symptoms in children 3
  • In anaphylaxis, chlorpheniramine is considered a second-line therapy to epinephrine and should never be administered alone 2
  • For acute allergic reactions requiring parenteral administration, the dosage is age-dependent:
    • Children >12 years: 10 mg IM or IV slowly 2
    • Children 6 to 12 years: 5 mg IM or IV slowly 2
    • Children 6 months to 6 years: 2.5 mg IM or IV slowly 2
    • Children <6 months: 250 µg/kg IM or IV slowly 2

Important Considerations and Precautions

  • Sedation is a common adverse effect and appears to be more prevalent in younger children (2-5 years) 4
  • Chlorpheniramine should not be used as the sole treatment for anaphylaxis, as H1 antihistamines are considered second-line therapy to epinephrine 2
  • The combination of diphenhydramine and ranitidine (H1 and H2 blockers) is superior to diphenhydramine alone for managing anaphylaxis, but both are secondary to epinephrine 2
  • For dystonic reactions, diphenhydramine (1-2 mg/kg or 25-50 mg/dose parenterally) can be administered instead of chlorpheniramine 5

Monitoring

  • Monitor for sedation, especially in younger children 4
  • Be aware of potential drug interactions with other CNS depressants
  • In emergency settings such as anaphylaxis, monitor vital signs and response to treatment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetics and efficacy of chlorpheniramine in children.

The Journal of allergy and clinical immunology, 1982

Guideline

Metoclopramide Administration in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.